Treatment of hypercholesterolemia in the Watanabe rabbit using allogeneic hepatocellular transplantation under a regeneration stimulus

被引:36
作者
Eguchi, S [1 ]
Rozga, J [1 ]
Lebow, LT [1 ]
Chen, SC [1 ]
Wang, CC [1 ]
Rosenthal, R [1 ]
Fogli, L [1 ]
Hewitt, WR [1 ]
Middleton, Y [1 ]
Demetriou, AA [1 ]
机构
[1] CEDARS SINAI MED CTR,DEPT SURG,LIVER SUPPORT RES LAB,LOS ANGELES,CA 90048
关键词
D O I
10.1097/00007890-199609150-00008
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Numerous studies have reported successful allotransplantation of hepatocytes. However, none have shown long-term correction of a liver-related metabolic defect, In this study, we used a method of regional hepatocyte transplantation and subsequent induction of transplanted cell proliferation by regeneration response in the transplant-bearing liver lobes, New Zealand White rabbits were used as cell donors and Watanabe heritable hyperlipidemic (WHHL) rabbits were used as cell recipients (2x10(8) cells/rabbit). All recipient rabbits were maintained on daily cyclosporine, Two weeks after baseline serum cholesterol determination, group I WHHL rabbits (n=7) received an infusion of cells into the right lateral liver lobe, and a loose ligature was placed around the portal venous branch supplying the anterior lobe, After 1 week, to allow engraftment, the portal venous branch was ligated, which resulted in the atrophy of the affected liver parenchyma and induction of hyperplasia in the transplant-bearing liver tissue, Group II rabbits (n=6) were transplanted with New Zealand White hepatocytes without portal branch ligation (PBL) and group III rabbits (n=4) were subjected to sham transplantation (saline) and PBL, The experimental period extended to 150 days after transplantation. All WHHL rabbits transplanted with normal hepatocytes showed reduction in serum cholesterol and low-density lipoprotein (LDL) levels, Group I(PBL-stimulated) recipients demonstrated a more pronounced and sustained effect than group II animals (P<0.05). Group III controls showed only a slight, typical for aging decrease in serum cholesterol, Group I recipient livers perfused with LDL labeled with 1,1'-dioctadecyl-3,3,3',3'-tetramethyl indocarbocyanine perchlorate (DiI) showed much higher numbers of DiI-LDL-positive hepatocytes than those of group II recipients, In conclusion, a liver regeneration stimulus enhanced the population of transplanted hepatocytes and their functional effect in a large animal model of inborn error of liver metabolism.
引用
收藏
页码:588 / 593
页数:6
相关论文
共 47 条
  • [1] LIVER-TRANSPLANTATION TO PROVIDE LOW-DENSITY-LIPOPROTEIN RECEPTORS AND LOWER PLASMA-CHOLESTEROL IN A CHILD WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA
    BILHEIMER, DW
    GOLDSTEIN, JL
    GRUNDY, SM
    STARZL, TE
    BROWN, MS
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (26) : 1658 - 1664
  • [2] BILHEIMER DW, 1989, ARTERIOSCLER, V9, P158
  • [3] CHOWDHURY JR, 1991, SCIENCE, V254, P1802, DOI 10.1126/science.1722351
  • [4] CELLULAR HETEROGENEITY IN BINDING AND UPTAKE OF LOW-DENSITY-LIPOPROTEIN IN PRIMARY RAT HEPATOCYTES
    CORSETTI, JP
    SPARKS, JD
    SIKORA, B
    SPARKS, CE
    [J]. HEPATOLOGY, 1993, 17 (04) : 645 - 650
  • [5] EXPERIMENTAL HEPATOCYTE TRANSPLANTATION AND LIVER GENE-THERAPY
    DEMETRIOU, AA
    [J]. CELL TRANSPLANTATION, 1993, 2 (05) : 401 - 403
  • [6] DIETSCHY JM, 1983, J LIPID RES, V24, P469
  • [7] HELPER VIRUS-INDUCED T-CELL LYMPHOMA IN NONHUMAN-PRIMATES AFTER RETROVIRAL MEDIATED GENE-TRANSFER
    DONAHUE, RE
    KESSLER, SW
    BODINE, D
    MCDONAGH, K
    DUNBAR, C
    GOODMAN, S
    AGRICOLA, B
    BYRNE, E
    RAFFELD, M
    MOEN, R
    BACHER, J
    ZSEBO, KM
    NIENHUIS, AW
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) : 1125 - 1135
  • [8] FULLER BJ, 1988, J HEPATOL, V368, P7
  • [9] GOLDSTEIN JL, 1983, NEW ENGL J MED, V309, P288, DOI 10.1056/NEJM198308043090507
  • [10] TRANSPLANTATION OF GENETICALLY MODIFIED AUTOLOGOUS HEPATOCYTES INTO NONHUMAN-PRIMATES - FEASIBILITY AND SHORT-TERM TOXICITY
    GROSSMAN, M
    RAPER, SE
    WILSON, JM
    [J]. HUMAN GENE THERAPY, 1992, 3 (05) : 501 - 510